Ballentine Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
CAM
AT
WCM
SOADOR
KWM
AAM
CI
Ballentine Partners's HALO Position: Q2 2026 in Review
Ballentine Partners increased its Halozyme (HALO) stake by 1.1% in Q2 2026, buying an estimated $4.71K and bringing the position to 6,331 shares worth $496K. The position accounts for 0.01% of the portfolio, ranked #571.
Ballentine Partners first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. 101 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Ballentine Partners held 6,331 shares of Halozyme worth $496K as of Q2 2026.
- Ballentine Partners bought 69 Halozyme shares in Q2 2026, an estimated $4.71K.
- Halozyme made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #571 holding.
- Ballentine Partners first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
- 101 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.